MSS/ MMRp

Who we are

  • April 5, 2022
    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
  • April 5, 2022
    Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
  • April 5, 2022
    Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
  • April 5, 2022
    Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
  • April 5, 2022
    alloSHRINK – Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
  • April 5, 2022
    An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers
  • April 5, 2022
    A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
  • April 5, 2022
    Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3)
  • April 5, 2022
    Immunotherapy for the Treatment of Advanced Solid Tumor
  • April 5, 2022
    Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer